| GLESX | MLPOX | GLESX / MLPOX | |
| Total Expense Ratio | 1.11 | 6.38 | 17% |
| Annual Report Gross Expense Ratio | 1.17 | 6.38 | 18% |
| Fund Existence | 8 years | 16 years | - |
| Gain YTD | 3.241 | 1.781 | 182% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 1000 | 500,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 443M | 1.03B | 43% |
| Annual Yield % from dividends | 3.19 | 5.42 | 59% |
| Returns for 1 year | -6.48 | 3.54 | -183% |
| Returns for 3 years | 32.71 | 69.00 | 47% |
| Returns for 5 years | 138.91 | 244.71 | 57% |
| Returns for 10 years | N/A | 101.85 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBE | 78.44 | 0.47 | +0.60% |
| Invesco Biotechnology & Genome ETF | |||
| AOD | 9.53 | 0.03 | +0.32% |
| abrdn Total Dynamic Dividend Fund | |||
| PPEM | 28.29 | 0.02 | +0.06% |
| Putnam PanAgora ESG Emerg Mkts Eq ETF | |||
| CPNJ | 26.77 | N/A | +0.01% |
| Calamos Nasdaq-100 Str Alt Prt ETF-Jun | |||
| TJAN | 27.11 | N/A | -0.01% |
| Innovator Equity Defined Protection ETF - 2 Yr to January 2027 | |||